These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Development of primary varicella infection during infliximab treatment for psoriasis. Balato N; Gaudiello F; Balato A; Ayala F J Am Acad Dermatol; 2009 Apr; 60(4):709-10. PubMed ID: 19293027 [No Abstract] [Full Text] [Related]
5. Severe neutrophilia induced by infliximab for psoriasis. de Oliveira JP; Levy A; Morel P; Guibal F Br J Dermatol; 2008 Jan; 158(1):200-1. PubMed ID: 18028489 [No Abstract] [Full Text] [Related]
6. Development of bullous pemphigoid during treatment of psoriasis with adalimumab. Stausbøl-Grøn B; Deleuran M; Sommer Hansen E; Kragballe K Clin Exp Dermatol; 2009 Oct; 34(7):e285-6. PubMed ID: 19438555 [No Abstract] [Full Text] [Related]
8. Dermatitis during efalizumab treatment in a patient with psoriasis vulgaris. de Groot M; de Rie MA; Bos JD Br J Dermatol; 2005 Oct; 153(4):843-4. PubMed ID: 16181475 [No Abstract] [Full Text] [Related]
9. Autoimmune hepatitis in two psoriasis patients treated with inflixmab. Goujon C; Dahel K; Bérard F; Guillot I; Gunera-Saad N; Nicolas JF J Am Acad Dermatol; 2010 Aug; 63(2):e43-4. PubMed ID: 20633783 [No Abstract] [Full Text] [Related]
10. Immune thrombocytopenia associated with efalizumab therapy for psoriasis. Warkentin TE; Kwon P Ann Intern Med; 2005 Nov; 143(10):761-3. PubMed ID: 16287807 [No Abstract] [Full Text] [Related]
11. Severe myalgia associated with brodalumab treatment in a patient with psoriasis. Ichiyama S; Matano Y; Hoashi T; Kanda N; Nagayama H; Saeki H J Dermatol; 2018 Dec; 45(12):e327-e328. PubMed ID: 29782052 [No Abstract] [Full Text] [Related]
12. Two cases of atopic dermatitis-like conditions induced in psoriasis patients treated with infliximab. Vestergaard C; Deleuran M; Kragballe K J Eur Acad Dermatol Venereol; 2007 Oct; 21(9):1272-4. PubMed ID: 17894730 [No Abstract] [Full Text] [Related]
13. Development of linear IgA bullous dermatosis in a patient with psoriasis taking ustekinumab. Becker JG; Mundi JP; Newlove T; Mones J; Shupack J J Am Acad Dermatol; 2012 Oct; 67(4):e150-1. PubMed ID: 22980274 [No Abstract] [Full Text] [Related]
14. Hepatitis: a rare, but important, complication of infliximab therapy for psoriasis. Wahie S; Alexandroff A; Reynolds NJ Clin Exp Dermatol; 2006 May; 31(3):460-1. PubMed ID: 16681606 [No Abstract] [Full Text] [Related]
15. Gastric MALT lymphoma in a patient receiving infliximab for psoriasis. Girard C; Guillot B; Bessis D Br J Dermatol; 2008 Aug; 159(2):497-8. PubMed ID: 18547313 [No Abstract] [Full Text] [Related]
16. Guselkumab (Tremfya) for psoriasis. Med Lett Drugs Ther; 2017 Nov; 59(1533):179-180. PubMed ID: 29125591 [No Abstract] [Full Text] [Related]
17. Anti IL-17 flared psoriasis in a patient on secukinumab. Noell C; McQuade B; Gottlieb A; Rosmarin D Dermatol Ther; 2017 Jul; 30(4):. PubMed ID: 28547879 [No Abstract] [Full Text] [Related]
18. Eczematous eruption in patients with psoriasis during risankizumab treatment. Kromer C; Schön MP; Mössner R Eur J Dermatol; 2020 Oct; 30(5):599-601. PubMed ID: 33185530 [No Abstract] [Full Text] [Related]
19. Potential complications associated with the use of biologic agents for psoriasis. Zeichner JA; Lebwohl M Dermatol Clin; 2007 Apr; 25(2):207-13, vii. PubMed ID: 17430757 [TBL] [Abstract][Full Text] [Related]
20. Adalimumab may be better or no worse than methotrexate in the treatment of psoriasis. Nijsten T; Spuls PI Br J Dermatol; 2008 Jul; 159(1):257-8. PubMed ID: 18489593 [No Abstract] [Full Text] [Related] [Next] [New Search]